Perioperative considerations in the paediatric patient with congenital and acquired coagulopathy

Area of Science:

• Pediatric Anesthesiology
• Hematology
• Surgical Hemostasis

Background:

• Children, especially neonates and infants, face high risks of perioperative coagulopathy due to immature hemostatic systems and undiagnosed bleeding disorders.
• Traditional coagulation tests are being supplemented by dynamic monitoring strategies like viscoelastic testing for high-risk procedures.
• A critical gap exists in age-specific reference values for diagnosing and managing pediatric coagulopathies.

Purpose of the Study:

• To review current perioperative guidelines, monitoring techniques, and treatment options for pediatric coagulopathy.
• To highlight the need for validated, age-specific data for effective management.
• To emphasize the role of expert consensus in guiding perioperative care in the absence of robust evidence.

Main Methods:

• Review of current perioperative guidelines and monitoring strategies for pediatric coagulopathy.
• Discussion of viscoelastic testing and platelet function analysis as advanced monitoring tools.
• Examination of targeted treatment modalities including tranexamic acid, factor concentrates, and blood component transfusions.

Main Results:

• Viscoelastic testing is increasingly adopted for monitoring coagulopathy in high-risk pediatric surgical patients.
• Platelet function analyzers offer promising screening for platelet abnormalities.
• Current management relies on expert consensus due to a lack of prospective studies with age-specific data.

Conclusions:

• Effective perioperative management of pediatric coagulopathy requires age-specific reference values and validated goal-directed strategies.
• Expert consensus should guide management until further research provides necessary data.
• Individualized treatment approaches are crucial for addressing bleeding disorders in pediatric surgical patients.